XML 37 R25.htm IDEA: XBRL DOCUMENT v3.23.1
Revenue Revenue Recognition and Deferred Revenue (Tables)
 3 Months Ended
Mar. 31, 2023
Revenue Recognition and Deferred Revenue [Abstract]  
Revenue from External Customers by Geographic Areas
The following tables present our revenue disaggregated by geographic area, species and major product category:
Revenue by geographic area
Three Months Ended
March 31,
(MILLIONS OF DOLLARS)20232022
United States$1,005 $1,020 
Australia82 65 
Brazil84 77 
Canada50 49 
Chile39 41 
China102 103 
France34 32 
Germany45 43 
Italy26 30 
Japan39 59 
Mexico39 35 
Spain33 33 
United Kingdom68 64 
Other developed markets122 115 
Other emerging markets215 202 
1,983 1,968 
Contract manufacturing & human health17 18 
Total Revenue$2,000 $1,986 
Revenue from External Customers by Major Species Revenue by major species
Three Months Ended
March 31,
(MILLIONS OF DOLLARS)20232022
U.S.
Companion animal$721 $774 
Livestock284 246 
1,005 1,020 
International
Companion animal504 489 
Livestock474 459 
978 948 
Total
Companion animal1,225 1,263 
Livestock758 705 
Contract manufacturing & human health17 18 
Total Revenue$2,000 $1,986 
Revenue from External Customers by Species Revenue by species
Three Months Ended
March 31,
(MILLIONS OF DOLLARS)20232022
Companion Animal:
Dogs and Cats$1,153 $1,199 
Horses72 64 
1,225 1,263 
Livestock:
Cattle399 364 
Swine142 154 
Poultry139 124 
Fish49 44 
Sheep and other29 19 
758 705 
Contract manufacturing & human health17 18 
Total Revenue$2,000 $1,986 
Schedule of Significant Product Revenues Revenue by major product category
Three Months Ended
March 31,
(MILLIONS OF DOLLARS)20232022
Parasiticides$432 $459 
Vaccines429 405 
Other pharmaceuticals294 254 
Dermatology292 311 
Anti-infectives288 285 
Animal health diagnostics93 98 
Medicated feed additives87 98 
Other non-pharmaceuticals68 58 
1,983 1,968 
Contract manufacturing & human health17 18 
Total Revenue$2,000 $1,986